New Weight Loss Drug Belviq Finally Available in U.S.

by Christopher Freeburn | June 10, 2013 12:13 pm

New Weight Loss Drug Belviq Finally Available in U.S.

pills 300x225 New Weight Loss Drug Belviq Finally Available in U.S.[1]Americans battling obesity will soon have access to a new medication that can help them lose weight[2].

This week, Eisai (ESALY[3]) will begin selling Arena Pharmaceutical‘s (ARNA[4]) anti-obesity treatment Belviq in the U.S. Though the drug received Food and Drug Administration clearance last year, its introduction was delayed by additional regulatory hurdles, PharmaTimes notes.

Arena will receive $65 million from Eisai now that the drug has reached the market and could receive $1.19 billion in additional payments, depending on sales.

After its approval, the U.S. Drug Enforcement Administration spent months reviewing the potential for users to abuse it[5]. The drug was ultimate placed on the Controlled Substance Act’s Schedule IV. That indicates that it has a low risk of abuse.

Qsymia, a rival weight-loss drug from Vivus (VVUS[6]), hit the market last year, but has seen relatively low sales[7].

Belviq is designed for adults who have a body mass index (BMI) higher than 30, or who have hypertension, high cholesterol or type 2 diabetes and a BMI of 27 or more.  It was originally rejected by the FDA in 2010[8].

Shares of Arena rose almost 2% in Monday midday trading.

Endnotes:
  1. [Image]: http://investorplace.com/wp-content/uploads/2012/10/pills.jpg
  2. to a new medication that can help them lose weight: http://www.pharmatimes.com/Article/13-06-10/Arena_Eisai_diet_drug_Belviq_finally_hits_US_market.aspx
  3. ESALY: http://studio-5.financialcontent.com/investplace/quote?Symbol=ESALY
  4. ARNA: http://studio-5.financialcontent.com/investplace/quote?Symbol=ARNA
  5. spent months reviewing the potential for users to abuse it: http://investorplace.com/2013/05/belviq-is-not-the-next-fen-phen-probably/
  6. VVUS: http://studio-5.financialcontent.com/investplace/quote?Symbol=VVUS
  7. but has seen relatively low sales: http://investorplace.com/2013/01/now-that-the-vivus-dust-has-settled/
  8. originally rejected by the FDA in 2010: http://investorplace.com/2012/06/fda-okays-arenas-belviq-shares-spike/

Source URL: http://investorplace.com/2013/06/new-weight-loss-drug-belviq-finally-available-in-u-s/
Short URL: http://invstplc.com/1nwKcjV